How I’m building a second income with high yielders GSK and Royal Dutch Shell

Edward Sheldon explains how he collects regular dividend cheques from Royal Dutch Shell plc (LON: RDSB) and GlaxoSmithKline plc (LON: GSK).

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In recent years, I’ve been focusing on building up a portfolio of FTSE 100 dividend stocks within my ISA. My goal? To generate a growing tax-free income stream that I can eventually live off.

Currently, I have just under 20 stocks in my dividend portfolio, across a range of sectors. Yields on my holdings range from around 3.5%, all the way up to 7%. Here’s a look at two stocks within my portfolio that both yield over 5% right now.

Royal Dutch Shell

Royal Dutch Shell (LSE: RDSB) needs little introduction. The company is a multinational oil and gas company that is one of the largest companies in the world. With a market capitalisation of over £200bn, Shell is the largest name in the FTSE 100 index.

There’s a lot to like about it from a dividend-investing perspective. For starters, the stock offers a huge yield of 5.4% at present. You can’t deny that looks extremely appealing in today’s low-interest-rate environment, where it’s a struggle to find a bank account offering over 1%.

Furthermore, Shell also has a fantastic dividend track record. The company places a strong emphasis on rewarding investors with regular payouts and has not cut its dividend since World War II. That’s an amazing achievement when you consider that the oil price, and Shell’s profits, have fluctuated heavily in that time. Even when oil plummeted below $30/bbl in 2016, reducing profitability, Shell held its dividend steady.

Given its track record and its high yield, I’m happy holding the FTSE 100 stock in my dividend portfolio. Every quarter, I receive tax-free income from the company, for doing absolutely nothing.

GlaxoSmithKline

Another stock that I currently hold within my ISA dividend portfolio is GlaxoSmithKline (LSE: GSK). A global healthcare company, it specialises in pharmaceutical medicines, vaccines and consumer healthcare products and looks well placed to benefit from the world’s ageing population.

Like Shell, GSK also has a high yield at present. For the last few years, the company has paid shareholders 80p per share in dividends each year, which at the current share price of 1,550p, equates to a high yield of 5.2%.

There has been some concern in recent years that GSK’s dividend may be at risk of a cut. Earnings have been a little on the low side, and a potential acquisition of Pfizer’s consumer health business could have put pressure on the dividend. However, in late March, the company advised that it had withdrawn its interest in Pfizer, and also reassured investors that they could expect another payout of 80p per share this year, which was good news for income investors. As a result, I’m happy to continue holding GSK in my portfolio and I look forward to receiving more cash dividends from the company. 

It’s worth noting that when building a dividend portfolio, it’s important to always diversify over many different stocks to reduce risk. With that in mind, if you’re looking for more high-yield ideas for your own portfolio, why not take a look at the report below?

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in Royal Dutch Shell and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »